Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.
<h4>Unlabelled</h4>Vaccination against influenza is an important means of reducing morbidity and mortality in subjects at risk. The prevalent viral strains responsible for seasonal epidemics usually change annually, but the WHO recommendations for the 2011/2012-season in the Northern hem...
Guardado en:
Autores principales: | Micha Loebermann, Ulrich Voss, Seetha Meyer, Dietrich Bosse, Carlos Fritzsche, Sebastian Klammt, Silvius Frimmel, Diana Riebold, Emil C Reisinger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d3fa1e51bd454ab5bde3283392aa82cd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunogenicity of 2-dose pre-exposure rabies vaccine co-administered with quadrivalent influenza vaccine in children
por: Napaporn Chantasrisawad, et al.
Publicado: (2021) -
Immunogenicity of an oral rotavirus vaccine administered with prenatal nutritional support in Niger: A cluster randomized clinical trial.
por: Sheila Isanaka, et al.
Publicado: (2021) -
Correction: Immunogenicity of an oral rotavirus vaccine administered with prenatal nutritional support in Niger: A cluster randomized clinical trial.
por: Sheila Isanaka, et al.
Publicado: (2021) -
Efficacy of inactive bivalent and trivalent Streptococcus agalactiae bacteria (biotype 1 & 2) vaccines on tilapia, Oreochromis niloticus
por: Taukhid, et al.
Publicado: (2021) -
IMMUNOGENICITY OF THE THIRD GENERATION HEPATITIS B VACCINE (pre-S1/pre-S2/S)
por: E. V. Esaulenko, et al.
Publicado: (2018)